Jessica K. Formichella

Jessica K. Formichella is a patent litigation attorney with a primary focus on the pharmaceutical and biologics sectors, particularly in matters involving biosimilar products. Her practice, based at Walsh Pizzi O'Reilly Falanga LLP, consistently involves representing plaintiffs in complex intellectual property disputes. This is evident from her tracked appearances, all of which have been on the plaintiff side, including two instances as Lead Counsel in untitled cases, alongside her role as Local Counsel in other significant litigations.

Her notable case experience includes representing Amgen Inc. and Amgen Manufacturing Limited LLC in various patent infringement actions. She has served as counsel for Amgen in cases such as Amgen Inc. v. Sandoz Inc. and Amgen Inc. v. Samsung Bioepis Co., Ltd., as well as Amgen Inc. v. Amneal Pharmaceuticals, Inc. et al. These cases typically involve allegations of infringement concerning patents related to Amgen's innovative therapeutic products like Prolia and XGEVA against companies seeking to market biosimilar versions.

Formichella is admitted to practice in New Jersey and New York and before the U.S. District Court for the District of New Jersey. She earned her J.D., cum laude, from Seton Hall University School of Law in 2017, where she was Executive Editor for the Seton Hall Legislative Journal. She also holds a Bachelor of Arts, magna cum laude, in Political Science from Seton Hall University, received in 2014. Prior to joining her current firm, she served as a judicial law clerk for federal and state courts. No information regarding her regular appearance in PTAB or IPR proceedings was found in the public records reviewed.